11. 1YY2 NMR Conformational Analysis of LHRH and its analogues, NMR 21 Structures (2006)
11. 1YY2 NMR Conformational Analysis of LHRH and its analogues, NMR 21 Structures (2006).
10. 1YY1 NMR Conformational Analysis of LHRH and its analogues, NMR 21 Structures (2006)
10. 1YY1 NMR Conformational Analysis of LHRH and its analogues, NMR 21 Structures (2006).
9. 1YL9 3D Solution Structure of [Tyr3]Octreotate derivatives in DMSO, NMR 21 Structures (2005)
9. 1YL9 3D Solution Structure of [Tyr3]Octreotate derivatives in DMSO, NMR 21 Structures (2005).
8. 1YL8 3D Solution Structure of [Tyr3]Octreotate derivatives in DMSO, NMR 21 Structures (2005)
8. 1YL8 3D Solution Structure of [Tyr3]Octreotate derivatives in DMSO, NMR 21 Structures (2005).
1N9V Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Strucure-Function Relationship (Angiotensin-II), NMR 21 structures (2003)
7. 1N9V Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Strucure-Function Relationship (Angiotensin-II), NMR 21 structures (2003).
6. 1N9U Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Strucure-Function Relationship (Angiotensin-I), NMR 21 structures (2003)
6. 1N9U Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Strucure-Function Relationship (Angiotensin-I), NMR 21 structures (2003).
5. 1MNY Dimethyl propionate ester heme-containing cytochrome b5 (2002)
5. 1MNY Dimethyl propionate ester heme-containing cytochrome b5 (2002).
4. 1GOE Monitoring the structural consequences of Phe12->Dphe12 and Leu15->Aib15 substitution in h/r Corticotropin Releasing Hormone: Implications for design of CRH antagonists, NMR 40 models (2001)
4. 1GOE Monitoring the structural consequences of Phe12->Dphe12 and Leu15->Aib15 substitution in h/r Corticotropin Releasing Hormone: Implications for design of CRH antagonists, NMR 40 models (2001).
3. 1GO9 Monitoring the structural consequences of Phe12->Dphe12 and Leu15->Aib15 substitution in h/r Corticotropin Releasing Hormone: Implications for design of CRH antagonists, NMR Minimized Average Structure (2001)
3. 1GO9 Monitoring the structural consequences of Phe12->Dphe12 and Leu15->Aib15 substitution in h/r Corticotropin Releasing Hormone: Implications for design of CRH antagonists, NMR Minimized Average Structure (2001).
2. 2GIW Solution Structure of reduced Horse Heart cytochromes c, NMR, 40 structures (1998)
2. 2GIW Solution Structure of reduced Horse Heart cytochromes c, NMR, 40 structures (1998).